Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001516551-25-000022
Filing Date
2025-02-28
Accepted
2025-02-28 18:54:45
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1740786879.html 4/A  
1 FORM 4/A wk-form4a_1740786879.xml 4/A 5747
  Complete submission text file 0001516551-25-000022.txt   7624
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11250 EL CAMINO REAL, SUITE 100 C/O SKYE BIOSCIENCE, INC. SAN DIEGO CA 92130
Business Address
ARSENAULT KAITLYN (Reporting) CIK: 0001877242 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-42009 | Film No.: 25692896